$9.08 -0.02 (-0.22%) Zogenix Inc - NASDAQ

Jul. 28, 2016 | 04:00 PM

Quotes

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Last Trade: 9.08
Trade Time: Jul 28 04:00 PM Eastern Daylight Time
Change: -0.02 (-0.22%)
Prev Close: 9.10
Open: 9.09
Bid: 9.08
Ask: 9.09
  1. No results found.
  1. Mid-Day Market Update: HP Slides Following Q4 Results; Deere Shares Surge

    Benzinga | Nov. 25, 2015 | 12:48PM EST
  2. Monday's After-Hours Movers: IBM, Sonic, Flextronics And More

    Benzinga | Oct. 19, 2015 | 16:43PM EST
  3. Zogenix Reports Positive Top-Line Results From Relday(TM) Phase 1b Multi-Dose Clinical Trial

    Benzinga | Sep. 30, 2015 | 08:01AM EST
  4. Mid-Day Market Update: Receptos Jumps After Merger News; Marten Transport Shares Slide

    Benzinga | Jul. 15, 2015 | 13:03PM EST
  5. Mid-Afternoon Market Update: Micron Gains On Rumor Of Tsinghua Bid; Navient Shares Drop

    Benzinga | Jul. 14, 2015 | 15:14PM EST
  6. Mid-Morning Market Update: Markets Edge Higher; Centene To Acquire Health Net For $6.3B

    Benzinga | Jul. 2, 2015 | 11:05AM EST
  7. Zogenix Announces New Efficacy Data from Long-Term Study of Low-Dose Fenfluramine for Treatment of Dravet Syndrome

    Benzinga | May. 27, 2015 | 08:32AM EST
  8. Zogenix Received FDA Approval, Now What?

    Benzinga | Feb. 2, 2015 | 13:27PM EST
  9. What Investors Are Watching Ahead of Zogenix's FDA Approval Decision

    Benzinga | Jan. 26, 2015 | 13:39PM EST
  10. What Investors Should Expect From Rockwell Medical's Next FDA Decision

    Benzinga | Jan. 7, 2015 | 16:22PM EST
  11. Brean Capital Initiates Coverage On Zogenix

    Benzinga | Dec. 29, 2014 | 16:44PM EST
  12. Events for the Week of Nov. 17-21, 2014

    Benzinga | Nov. 17, 2014 | 13:13PM EST
  13. Zogenix Reports Zohydro ER Shows Sustained 12-Hour Pain Relief

    Benzinga | Sep. 2, 2014 | 07:35AM EST
  14. Zohydro Gains Massachusetts Approval, Acts As Minor Catalyst For Zogenix

    Benzinga | Aug. 5, 2014 | 14:24PM EST
  15. Zogenix Announces Departure of Chief Commercial Officer, Scott Shively

    Benzinga | Aug. 1, 2014 | 16:05PM EST
Trading Center